THG enjoys sales growth but misses downgraded earnings guidance

MyProtein

THG has reported an increase in revenue but missed its downgraded EBITDA expectations.

Group revenues increased 2.7% to £2.2bn for the financial year ending December 31, which resulted in a two-year total sales growth of 38.8%.

 

Already have an account?

Want to read more?

Register for LIMITED guest access

Register now

Get premium access

£5 A MONTH for 3 months

Subscribe now